Ischemic Stroke in the Setting of Chronic Immune Thrombocytopenia in an Elderly Patient—A Therapeutic Dilemma

Chronic immune thrombocytopenia (ITP) carries a poor prognosis in the elderly patients. Increasing evidence proposes that a subgroup of patients with chronic ITP may be more susceptible to ischemic stroke. An 84-year-old Caucasian man with multiple ischemic stroke risk factors presented with acute onset of slurred speech, confusion, and unsteady gait. Physical examination and neurologic imaging were consistent with a new left thalamic infarct. Platelet counts ranged between 40 000 × 109/L and 65 000 × 109 /L. Antiplatelet therapy for his newly acquired stroke was not initiated considering his low platelet counts and for mildly symptomatic thrombocytopenia, and the patient was discharged home. Both hematologic and neurologic guidelines for the management of chronic ITP and stroke have contradictory goals. Although anticoagulation is mandated in acute stroke, ITP causes low platelet counts that increase bleeding complications.

[1]  J. Logie,et al.  Thromboembolic events among adult patients with primary immune thrombocytopenia in the United Kingdom General Practice Research Database , 2010, Haematologica.

[2]  Loïc Doeuvre,et al.  Cell‐derived microparticles: a new challenge in neuroscience , 2009, Journal of neurochemistry.

[3]  T. Olsen,et al.  Hemorrhagic and Ischemic Strokes Compared: Stroke Severity, Mortality, and Risk Factors , 2009, Stroke.

[4]  J. George,et al.  Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. , 2009, Blood.

[5]  J. Segal,et al.  Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review. , 2009, Blood.

[6]  J. Ney,et al.  A patient with idiopathic thrombocytopenic purpura presenting with an acute ischemic stroke. , 2008, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[7]  L. Horstman,et al.  Transendothelial migration of leukocytes is promoted by plasma from a subgroup of immune thrombocytopenic purpura patients with small‐vessel ischemic brain disease , 2008, American journal of hematology.

[8]  M. Luppi,et al.  Helicobacter pylori infection and chronic immune thrombocytopenic purpura: long-term results of bacterium eradication and association with bacterium virulence profiles. , 2007, Blood.

[9]  R. Stasi,et al.  Management of immune thrombocytopenic purpura in adults. , 2004, Mayo Clinic proceedings.

[10]  S. Proctor,et al.  Clinically significant newly presenting autoimmune thrombocytopenic purpura in adults: a prospective study of a population‐based cohort of 245 patients , 2003, British journal of haematology.

[11]  L. Horstman,et al.  Vascular dementia in patients with immune thrombocytopenic purpura. , 2002, Thrombosis research.

[12]  V. Blanchette,et al.  Immune thrombocytopenic purpura. , 2002, The New England journal of medicine.

[13]  B. Djulbegovic,et al.  The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet counts. , 2000, Archives of internal medicine.

[14]  J. George,et al.  Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. , 1996, Blood.

[15]  L. Horstman,et al.  Elevated platelet microparticles in transient ischemic attacks, lacunar infarcts, and multiinfarct dementias. , 1993, Thrombosis research.

[16]  T. Barbui,et al.  High risk of severe bleeding in aged patients with chronic idiopathic thrombocytopenic purpura. , 1991, Blood.